Author:
Okrój Marcin,Johansson Martin,Saxne Tore,Blom Anna M.,Hesselstrand Roger
Funder
Vetenskapsrådet
Narodowym Centrum Nauki
Alfred Österlunds Stiftelse (SE)
Greta och Johan Kock Stiftelse
Stiftelsen Konung Gustaf V:s 80-årsfond
Knut och Alice Wallenbergs Stiftelse (SE)
IngaBritt och Arne Lundbergs Forskningsstiftelse
grant for clinical research (ALF)
grant for clinical research (SUS)
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Balbir-Gurman A, Braun-Moscovici Y. Scleroderma – new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol. 2012;26:13–24.
2. Yoshizaki A, Sato S. Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol. 2015;27:1–9.
3. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–5.
4. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 1995;3:39–50.
5. Streicher K, Morehouse CA, Groves CJ, Rajan B, Pilataxi F, Lehmann KP, et al. The plasma cell signature in autoimmune disease. Arthritis Rheumatol. 2014;66:173–84.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献